ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,739Medicare Part D Prescriptions Filled, Including Refills

Rank: 79 out of 917

$498K Total Retail Price of All Prescriptions

Rank: 121 out of 917

560 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 560 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 560 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 9,463 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
LISINOPRIL 580 527 1 1
SIMVASTATIN 399 371 2 2
FUROSEMIDE 365 328 3 7
PRAVASTATIN SODIUM 344 281 4 20
ATENOLOL 336 321 5 12
OMEPRAZOLE 333 289 6 4
WARFARIN SODIUM 314 302 7 10
METFORMIN HCL 301 267 8 8
POTASSIUM CHLORIDE 278 274 9 16
LEVOTHYROXINE SODIUM 242 183 10 3
GLIPIZIDE 217 198 11 40
AMLODIPINE BESYLATE 211 185 12 5
METOPROLOL TARTRATE 200 198 13 11
HYDROCHLOROTHIAZIDE 178 174 14 9
CITALOPRAM HBR 150 104 15 15
TAMSULOSIN HCL 145 145 16 25
LOVASTATIN 145 113 16 19
LOSARTAN POTASSIUM 137 129 18 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 135 121 19 42
TRIAMTERENE-HCTZ 124 120 20 36
METFORMIN HCL ER 124 88 20 69
DIGOXIN 122 122 22 41
GABAPENTIN 121 113 23 17
PREDNISONE 104 77 24 34
DOXAZOSIN MESYLATE 101 98 25 74
LANTUS SOLOSTAR 100 79 26 63
DILTIAZEM 24HR CD 86 81 27 95
ZOLPIDEM TARTRATE 86 85 27 21
ATORVASTATIN CALCIUM 81 73 29 14
DILTIAZEM ER 81 81 29 106
CARVEDILOL 81 64 29 33
PROAIR HFA 74 67 32 35
ALENDRONATE SODIUM 69 69 33 23
PEN NEEDLE 67 60 34 99
RANITIDINE HCL 67 49 34 29
SPIRONOLACTONE 67 65 34 55
ISOSORBIDE MONONITRATE ER 66 53 37 70
GLIMEPIRIDE 65 54 38 54
PAROXETINE HCL 62 44 39 57
METOPROLOL SUCCINATE 62 58 39 18
LOSARTAN-HYDROCHLOROTHIAZIDE 60 60 41 62
NAPROXEN 60 51 41 107
ALLOPURINOL 58 58 43 31
SPIRIVA 58 58 43 45
NOVOLOG FLEXPEN 58 47 43 132
FINASTERIDE 57 53 46 77
TRAMADOL HCL 57 53 46 28
TRAZODONE HCL 56 24 48 22
MIRTAZAPINE 55 52 49 39
DILTIAZEM 24HR ER 55 55 49 177
AMITRIPTYLINE HCL 51 36 R 51 67
FELODIPINE ER 51 39 51 127
FLUTICASONE PROPIONATE 51 47 51 26
VENTOLIN HFA 51 28 51 135
HYDROCODONE-ACETAMINOPHEN 50 49 S3 55 6
CYMBALTA 50 27 55 56
LANTUS 50 50 55 37
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.